Small intestinal bacterial overgrowth in patients with systemic sclerosis

Small intestinal bacterial overgrowth (SIBO) is common in patients with systemic sclerosis (SSc) yet often goes underrecognized in clinical practice. In patients with SSc, untreated SIBO may result in marked morbidity and possible mortality. The pathogenesis of SIBO is multifactorial and relates to...

Full description

Saved in:
Bibliographic Details
Main Authors: Saara Rawn, Natalia Pitman, Karen Beattie, Ava Bazzaz, Maggie Larche
Format: Article
Language:English
Published: SAGE Publishing 2017-01-01
Series:Indian Journal of Rheumatology
Subjects:
Online Access:http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=6;spage=167;epage=170;aulast=Rawn
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832542995352649728
author Saara Rawn
Natalia Pitman
Karen Beattie
Ava Bazzaz
Maggie Larche
author_facet Saara Rawn
Natalia Pitman
Karen Beattie
Ava Bazzaz
Maggie Larche
author_sort Saara Rawn
collection DOAJ
description Small intestinal bacterial overgrowth (SIBO) is common in patients with systemic sclerosis (SSc) yet often goes underrecognized in clinical practice. In patients with SSc, untreated SIBO may result in marked morbidity and possible mortality. The pathogenesis of SIBO is multifactorial and relates to immune dysregulation, vasculopathy, and dysmotility. This article reviews various diagnostic approaches and therapeutic options for SIBO. Treatment modalities mainly include prokinetics, probiotics, and antibiotics.
format Article
id doaj-art-191f43e547cb483f9bac428fb1f27bf1
institution Kabale University
issn 0973-3698
0973-3701
language English
publishDate 2017-01-01
publisher SAGE Publishing
record_format Article
series Indian Journal of Rheumatology
spelling doaj-art-191f43e547cb483f9bac428fb1f27bf12025-02-03T11:54:50ZengSAGE PublishingIndian Journal of Rheumatology0973-36980973-37012017-01-01126167170Small intestinal bacterial overgrowth in patients with systemic sclerosisSaara RawnNatalia PitmanKaren BeattieAva BazzazMaggie LarcheSmall intestinal bacterial overgrowth (SIBO) is common in patients with systemic sclerosis (SSc) yet often goes underrecognized in clinical practice. In patients with SSc, untreated SIBO may result in marked morbidity and possible mortality. The pathogenesis of SIBO is multifactorial and relates to immune dysregulation, vasculopathy, and dysmotility. This article reviews various diagnostic approaches and therapeutic options for SIBO. Treatment modalities mainly include prokinetics, probiotics, and antibiotics.http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=6;spage=167;epage=170;aulast=RawnantibioticsGastrointestinal symptomsprobioticsprokineticsSclerodermaSmall bowel bacterial overgrowth
spellingShingle Saara Rawn
Natalia Pitman
Karen Beattie
Ava Bazzaz
Maggie Larche
Small intestinal bacterial overgrowth in patients with systemic sclerosis
Indian Journal of Rheumatology
antibiotics
Gastrointestinal symptoms
probiotics
prokinetics
Scleroderma
Small bowel bacterial overgrowth
title Small intestinal bacterial overgrowth in patients with systemic sclerosis
title_full Small intestinal bacterial overgrowth in patients with systemic sclerosis
title_fullStr Small intestinal bacterial overgrowth in patients with systemic sclerosis
title_full_unstemmed Small intestinal bacterial overgrowth in patients with systemic sclerosis
title_short Small intestinal bacterial overgrowth in patients with systemic sclerosis
title_sort small intestinal bacterial overgrowth in patients with systemic sclerosis
topic antibiotics
Gastrointestinal symptoms
probiotics
prokinetics
Scleroderma
Small bowel bacterial overgrowth
url http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=6;spage=167;epage=170;aulast=Rawn
work_keys_str_mv AT saararawn smallintestinalbacterialovergrowthinpatientswithsystemicsclerosis
AT nataliapitman smallintestinalbacterialovergrowthinpatientswithsystemicsclerosis
AT karenbeattie smallintestinalbacterialovergrowthinpatientswithsystemicsclerosis
AT avabazzaz smallintestinalbacterialovergrowthinpatientswithsystemicsclerosis
AT maggielarche smallintestinalbacterialovergrowthinpatientswithsystemicsclerosis